Takashi Takaya - Nippon Shinyaku G Personnel
| NPPNY Stock | USD 6.75 0.00 0.00% |
Insider
Takashi Takaya is G Personnel of Nippon Shinyaku Co
| Age | 63 |
| Phone | 81 7 5321 1111 |
| Web | https://www.nippon-shinyaku.co.jp |
Nippon Shinyaku Management Efficiency
The company has return on total asset (ROA) of 0.0878 % which means that it generated a profit of $0.0878 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1343 %, meaning that it generated $0.1343 on every $100 dollars invested by stockholders. Nippon Shinyaku's management efficiency ratios could be used to measure how well Nippon Shinyaku manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Richard MD | Collegium Pharmaceutical | 64 | |
| David Erickson | Evolus Inc | N/A | |
| Thomas Flow | Akanda Corp | 46 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| BCom BAcc | Akanda Corp | 44 | |
| Jeff Holm | Biofrontera | N/A | |
| Rami Levy | INC Research Holdings | 59 | |
| BComm BCom | Akanda Corp | 68 | |
| Eugene III | Biofrontera | 39 | |
| Mark Baldyga | Biofrontera | N/A | |
| Erica CPA | Biofrontera | 39 | |
| Tejinder Virk | Akanda Corp | 42 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Hermann Lubbert | Biofrontera | 68 | |
| John Weston | cbdMD Inc | N/A | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0878 |
Nippon Shinyaku Leadership Team
Elected by the shareholders, the Nippon Shinyaku's board of directors comprises two types of representatives: Nippon Shinyaku inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nippon. The board's role is to monitor Nippon Shinyaku's management team and ensure that shareholders' interests are well served. Nippon Shinyaku's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nippon Shinyaku's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kazuchika Takagaki, GM Director | ||
| Toru Nakai, Pres Director | ||
| Hitoshi Ishizawa, GM Director | ||
| Masafumi Taira, Corp Div | ||
| Hirokata Harada, Head Officer | ||
| Takashi Takaya, G Personnel | ||
| Takanori Edamitsu, GM Director | ||
| Shouzou Sano, GM MD | ||
| Koji Honma, Gen Dept | ||
| Masaya Toda, Head Officer |
Nippon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Nippon Shinyaku a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0878 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 3.4 B | |||
| Shares Outstanding | 269.41 M | |||
| Price To Earning | 19.16 X | |||
| Price To Book | 2.52 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 137.48 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nippon Pink Sheet Analysis
When running Nippon Shinyaku's price analysis, check to measure Nippon Shinyaku's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nippon Shinyaku is operating at the current time. Most of Nippon Shinyaku's value examination focuses on studying past and present price action to predict the probability of Nippon Shinyaku's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nippon Shinyaku's price. Additionally, you may evaluate how the addition of Nippon Shinyaku to your portfolios can decrease your overall portfolio volatility.